Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects.
about
Monoclonal antibodies for the treatment of osteoarthritis.Transmission pathways and mediators as the basis for clinical pharmacology of pain.Cough reflex hypersensitivity: A role for neurotrophins.[EXPRESS] Monoclonal antibodies for chronic pain: a practical review of mechanisms and clinical applications.Neuropathic pain and dry eye.Anti-nerve growth factor therapy attenuates cutaneous hypersensitivity and musculoskeletal discomfort in mice with osteoporosis.
P2860
Safety, tolerability, pharmacokinetics, and efficacy of AMG 403, a human anti-nerve growth factor monoclonal antibody, in two phase I studies with healthy volunteers and knee osteoarthritis subjects.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Safety, tolerability, pharmaco ...... knee osteoarthritis subjects.
@ast
Safety, tolerability, pharmaco ...... knee osteoarthritis subjects.
@en
type
label
Safety, tolerability, pharmaco ...... knee osteoarthritis subjects.
@ast
Safety, tolerability, pharmaco ...... knee osteoarthritis subjects.
@en
prefLabel
Safety, tolerability, pharmaco ...... knee osteoarthritis subjects.
@ast
Safety, tolerability, pharmaco ...... knee osteoarthritis subjects.
@en
P2093
P2860
P1476
Safety, tolerability, pharmaco ...... knee osteoarthritis subjects.
@en
P2093
Daniel Mytych
David Sciberras
Gary J Williams
Jason M Gow
John P Gibbs
Shawn L Searle
Wayne H Tsuji
P2860
P2888
P356
10.1186/S13075-015-0797-9
P577
2015-10-08T00:00:00Z
P5875
P6179
1047186740